MiMedx Group, Inc. Financials

Market Capitalization $936.4 Million as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	23.48
Forward PE	20.45
Price to Sales TTM	$2.66
Price to Book MRQ	$4.61
Enterprise to Revenue	2.31
Enterprise to EBITDA	12.97

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	11.40%
Operating Margin	9.35%
Return on Assets TTM	13.79%
Return on Equity TTM	22.29%

Income Statement

Revenue TTM	$352,375,008
Revenue per Share TTM	$2.39
Quarterly Revenue Growth	4.10%
Gross Profit TTM	$288,731,008
EBITDA	$63,735,000
Net Income to Common TTM	$39,960,000
Diluted EPS TTM	$0.27
Quarterly Earnings Growth YoY	-24.20%

Balance Sheet

Total Cash MRQ	$106,431,000
Total Cash per Share MRQ	$0.72
Total Debt MRQ	$
Total Debt to Equity MRQ	9.20
Current Ratio MRQ	4.70
Book Value per Share MRQ	$1.37

Cash Flow

Operating Cash Flow TTM	$65,519,000
Levered Free Cash Flow TTM	$53,104,876

MDXG Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	146,932,032
Float Shares	109,326,170
Avg 10 Volume	728,960
Avg 30 Volume	None
Shares Short	4,998,557
Short Ratio	8.93
Short % of Shares	4.24%
% Held by Insiders	1.71%
% Held by Institutions	70.12%

Stock Price Summary

Beta	1.80
Fifty Two Week Low	$5.47
Fifty Two Week High	$10.14
Fifty Two Week Change	-7.41%
Day 50 MA	$6.53
Day 200 MA	$7.49

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2008-04-02